Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Milestone Scientific (MLSS) EBT Margin (2016 - 2025)

Historic EBT Margin for Milestone Scientific (MLSS) over the last 16 years, with Q3 2025 value amounting to 48.89%.

  • Milestone Scientific's EBT Margin rose 92300.0% to 48.89% in Q3 2025 from the same period last year, while for Sep 2025 it was 74.66%, marking a year-over-year decrease of 224500.0%. This contributed to the annual value of 54.62% for FY2024, which is 164200.0% up from last year.
  • According to the latest figures from Q3 2025, Milestone Scientific's EBT Margin is 48.89%, which was up 92300.0% from 63.83% recorded in Q2 2025.
  • Milestone Scientific's 5-year EBT Margin high stood at 12.06% for Q2 2024, and its period low was 174.8% during Q2 2022.
  • Moreover, its 5-year median value for EBT Margin was 71.68% (2023), whereas its average is 74.34%.
  • As far as peak fluctuations go, Milestone Scientific's EBT Margin skyrocketed by 17875000bps in 2021, and later plummeted by -759000bps in 2025.
  • Milestone Scientific's EBT Margin (Quarter) stood at 54.3% in 2021, then plummeted by -63bps to 88.66% in 2022, then increased by 2bps to 86.56% in 2023, then dropped by -17bps to 101.09% in 2024, then skyrocketed by 52bps to 48.89% in 2025.
  • Its EBT Margin was 48.89% in Q3 2025, compared to 63.83% in Q2 2025 and 89.35% in Q1 2025.